- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03462602
Nasogastric Tube in Pancreatic Surgery
Randomized Clinical Trial for Evaluation of the Use of Nasogastric Tube Decompression After Pancreatic Surgery
Introduction: The value of routine nasogastric tube (NGT) decompression after pancreatic surgeries is not yet established. Previous studies in the setting of abdominal surgery suggested that the use of NGT does not accomplish any of its intended goals.
Methods/design: This is a prospective, randomized, controlled multicenter trial with two treatment arms. One group underwent pancreatic surgeries with routine NGT and was left in place after surgery until the patient passed flatus or stool. The other group underwent pancreatic surgeries without receiving NGT decompression, in which the NGT was removed at the end of surgery.
Discussion: Routine NGT decompression after pancreatic surgeries does or does not appear to have its anticipated advantages would be discovered in this RCT.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Hang Zhang, doctor
- Phone Number: +8602783665314
- Email: okashiiyo@126.com
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 430000
- Tongji Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with age between 18 - 80 years.
- Patients underwent any kind of pancreatic surgeries, including but not limited to PD, distal pancreatectomy, central pancreatectomy, pancreatic enucleation, etc.
- Patients accepted the trial and could completed a written consent.
Exclusion Criteria:
- Combined with digestive tract obstruction before the surgery.
- History of upper abdominal surgery.
- Serious heart, brain, lung, metabolic diseases history.
- Pregnant women.
- Unwillingness or inability to consent for the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: NGT group
|
After induction of anesthesia, a 14- or 16-Fr single-lumen NGT was placed in all patients.
Its intragastric position was confirmed by intraoperative palpation.
Randomization to the NGT or non-NGT group was performed on completion of surgery by computer-generated randomization provided by the supervision department.The NGT was retained until the return of bowel function (passage of flatus or passage of stool) in the patients assigned to the NGT group.
|
Experimental: non-NGT group
|
After induction of anesthesia, a 14- or 16-Fr single-lumen NGT was placed in all patients.
Its intragastric position was confirmed by intraoperative palpation.
Randomization to the NGT or non-NGT group was performed on completion of surgery by computer-generated randomization provided by the supervision department.The NGT was removed in the operation room immediately after the surgery in those assigned to the non-NGT group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to flatus
Time Frame: 24 months
|
It's described as the time patients to get flatus after operation
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pulmonary complication
Time Frame: 24 months
|
It was confirmed by clinical symptoms and CXR
|
24 months
|
Wound infection
Time Frame: 24 months
|
Superficial or deep surgical-site infections are both considered and should be reported in medical records.
Superficial infections are considered when skin or subcutaneous tissue is involved, whereas deep infection is considered when extending into the fascial layer.
|
24 months
|
Anastomotic leak
Time Frame: 24 months
|
Including any type of Anastomotic leak, pancreatic fistula, bile leakage, etc.
|
24 months
|
Incisional hernia
Time Frame: 24 months
|
Hernia or separation that occurred through a surgical incision in the abdominal wall deriving either from laparotomy or trocar incisions.
All available data will be considered from medical records.
|
24 months
|
Length of Stay
Time Frame: 24 months
|
Define as the day after surgery to dismiss.
|
24 months
|
Gastric upset
Time Frame: 24 months
|
Any symptoms described by the subjects.
|
24 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Renyi Qin, pHD, Tongji Hospital
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- TJDBPS04
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatic Surgery
-
B. Braun Melsungen AGCompletedPlasma Volume Replacement | Surgery of the Pancreatic HeadGermany
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Università Vita-Salute San RaffaeleCompletedPancreatic Cancer | Pancreatic SurgeryItaly
-
GCS Ramsay Santé pour l'Enseignement et la RechercheNot yet recruiting
-
Massachusetts General HospitalAmerican Society for Gastrointestinal EndoscopyWithdrawnPancreatic Cancer | Pancreatic Diseases | Pancreatic Cyst | Pancreatic Surgery | Pancreatic Duct Stenting | Distal Pancreatectomy | Pancreatic DuctsUnited States
-
Ruijin HospitalShanghai Jiao Tong University School of MedicineRecruitingPancreatic Ductal Adenocarcinoma | Minimally Invasive SurgeryChina
-
Sunnybrook Health Sciences CentreUniversity Health Network, Toronto; Baxter Healthcare Corporation; The Ottawa... and other collaboratorsCompletedSurgery | Surgery--Complications | Pancreas Adenocarcinoma | Pancreas Cancer | Pancreas Disease | Pancreas; Fistula | Surgery Site FistulaCanada
-
Peking Union Medical College HospitalRecruitingThe Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer (MIOPP)Surgery | Pancreatic CarcinomaChina
-
Hospital General Universitario de AlicanteNot yet recruitingSurgery--Complications | Pancreatic Fistula | Pancreas Disease
-
University Hospital, MontpellierUniversité Montpellier; Association de Chirurgie hepato-bilio-pancreatique... and other collaboratorsCompletedPancreatic Cancer | Pancreatic SurgeryFrance
Clinical Trials on NGT group
-
University Hospitals of North Midlands NHS TrustWithdrawnStroke | DysphagiaUnited Kingdom
-
The University of Texas Health Science Center,...TerminatedEnteral Feeding in BronchiolitisUnited States
-
Centre Hospitalier Universitaire, AmiensUniversity Hospital, Angers; Centre Hospitalier Universitaire Dijon; Centre Hospitalier... and other collaboratorsNot yet recruitingSmall Bowel Obstruction AdhesionFrance
-
Bristol-Myers SquibbRecruiting
-
University of Sao Paulo General HospitalCompletedOsteoarthritis, Knee
-
Charite University, Berlin, GermanyDepartment of Neurology, Charité - Universitätsmedizin Berlin, Germany; Department...Unknown
-
Aqua Medical Services (Pvt) LtdCompletedLumbar Disc Herniation | Spinal Disk Injury | ProtrusionPakistan
-
Cairo UniversityCompleted
-
Al-Azhar UniversityCompleted
-
Zagazig UniversityCompleted